TRILINK BIOTECHNOLOGIES
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 May 2022)
What this means for you
Registered since 15 Nov 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86474677
- Registration number
- 5082759
- Mark type
- Design + words
- Filed
- 08 Dec 2014
- Published for opposition
- 02 Feb 2016
- Registered
- 15 Nov 2016
- Attorney of record
- Lindsay J. Hulley
Goods and services
- Class 001 — Chemicals: Nucleic acid products, namely, DNA, RNA and/or mRNA oligonucleotides, modified nucleosides and reagents for nucleic acid synthesis, and chemical reagents for non-medical research; Nucleic acid reagents, agents, preparations and substances for scientific purposes
- Class 005 — Pharmaceuticals: Nucleic acid reagents, agents, preparations and substances for medical purposes
Owner
- TRILINK BIOTECHNOLOGIES, LLC, SAN DIEGO, CA, US
- TriLink BioTechnologies, Inc., San Diego, CA, US
- TriLink BioTechnologies, Inc., San Diego, CA, US
- TriLink BioTechnologies, Inc., San Diego, CA, US
Prior registrations
Prosecution history
- 15 Nov 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 20 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Sept 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Sept 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 27 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 May 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 May 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 May 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Nov 2021 — TEAS SECTION 8 & 15 RECEIVED
- 15 Nov 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED